Published in Circ Heart Fail on September 24, 2009
Chronic heart failure reduces Akt phosphorylation in human skeletal muscle: relationship to muscle size and function. J Appl Physiol (1985) (2010) 1.59
Impaired muscle protein anabolic response to insulin and amino acids in heart failure patients: relationship with markers of immune activation. Clin Sci (Lond) (2010) 1.44
Chronic heart failure decreases cross-bridge kinetics in single skeletal muscle fibres from humans. J Physiol (2010) 1.17
Resistance training alters skeletal muscle structure and function in human heart failure: effects at the tissue, cellular and molecular levels. J Physiol (2011) 1.03
Muscle disuse alters skeletal muscle contractile function at the molecular and cellular levels in older adult humans in a sex-specific manner. J Physiol (2014) 1.02
Age-related slowing of myosin actin cross-bridge kinetics is sex specific and predicts decrements in whole skeletal muscle performance in humans. J Appl Physiol (1985) (2013) 0.98
Metabolomic distinction and insights into the pathogenesis of human primary dilated cardiomyopathy. Eur J Clin Invest (2010) 0.97
Effect of resistance training on physical disability in chronic heart failure. Med Sci Sports Exerc (2011) 0.96
Myofilament protein alterations promote physical disability in aging and disease. Exerc Sport Sci Rev (2013) 0.94
Molecular mechanisms underlying skeletal muscle weakness in human cancer: reduced myosin-actin cross-bridge formation and kinetics. J Appl Physiol (1985) (2013) 0.92
Intrinsic skeletal muscle alterations in chronic heart failure patients: a disease-specific myopathy or a result of deconditioning? Heart Fail Rev (2012) 0.92
Acute Dietary Nitrate Intake Improves Muscle Contractile Function in Patients With Heart Failure: A Double-Blind, Placebo-Controlled, Randomized Trial. Circ Heart Fail (2015) 0.91
Skeletal muscle myofilament adaptations to aging, disease, and disuse and their effects on whole muscle performance in older adult humans. Front Physiol (2014) 0.89
Skeletal muscle mitochondrial density, gene expression, and enzyme activities in human heart failure: minimal effects of the disease and resistance training. J Appl Physiol (1985) (2012) 0.88
Age-related structural alterations in human skeletal muscle fibers and mitochondria are sex specific: relationship to single-fiber function. J Appl Physiol (1985) (2014) 0.86
Metabolic and structural impairment of skeletal muscle in heart failure. Heart Fail Rev (2013) 0.84
Comparative biomechanics of thick filaments and thin filaments with functional consequences for muscle contraction. J Biomed Biotechnol (2010) 0.83
Skeletal muscle protein metabolism in human heart failure. Curr Opin Clin Nutr Metab Care (2013) 0.81
Chronic disuse and skeletal muscle structure in older adults: sex-specific differences and relationships to contractile function. Am J Physiol Cell Physiol (2015) 0.81
Molecular determinants of force production in human skeletal muscle fibers: effects of myosin isoform expression and cross-sectional area. Am J Physiol Cell Physiol (2015) 0.77
Skeletal muscle ultrastructure and function in statin-tolerant individuals. Muscle Nerve (2015) 0.77
Central and peripheral quadriceps fatigue in congestive heart failure. Int J Cardiol (2012) 0.77
Discerning primary and secondary factors responsible for clinical fatigue in multisystem diseases. Biology (Basel) (2014) 0.77
Random myosin loss along thick-filaments increases myosin attachment time and the proportion of bound myosin heads to mitigate force decline in skeletal muscle. Arch Biochem Biophys (2014) 0.76
Reduced rate of knee extensor torque development in older adults with knee osteoarthritis is associated with intrinsic muscle contractile deficits. Exp Gerontol (2015) 0.76
Directly Measured Physical Function in Cardiac Rehabilitation. J Cardiopulm Rehabil Prev (2017) 0.75
MODERATE-INTENSITY RESISTANCE EXERCISE ALTERS SKELETAL MUSCLE MOLECULAR AND CELLULAR STRUCTURE AND FUNCTION IN INACTIVE, OLDER ADULTS WITH KNEE OSTEOARTHRITIS. J Appl Physiol (1985) (2017) 0.75
Muscle structure and theories of contraction. Prog Biophys Biophys Chem (1957) 32.09
Muscle mass, muscle strength, and muscle fat infiltration as predictors of incident mobility limitations in well-functioning older persons. J Gerontol A Biol Sci Med Sci (2005) 6.42
Effect of Ca2+ on cross-bridge turnover kinetics in skinned single rabbit psoas fibers: implications for regulation of muscle contraction. Proc Natl Acad Sci U S A (1988) 5.09
Firing patterns of motor units in normal rats. Nature (1985) 3.63
Cancer cachexia is regulated by selective targeting of skeletal muscle gene products. J Clin Invest (2004) 3.09
The effect of ageing and immobilization on structure and function of human skeletal muscle fibres. J Physiol (2003) 2.15
Skeletal muscle function and its relation to exercise tolerance in chronic heart failure. J Am Coll Cardiol (1997) 2.08
Quantitative determination of myosin and actin in rabbit skeletal muscle. J Mol Biol (1983) 2.04
Acute quadriplegia and loss of muscle myosin in patients treated with nondepolarizing neuromuscular blocking agents and corticosteroids: mechanisms at the cellular and molecular levels. Crit Care Med (2000) 1.96
Relation of the renin-angiotensin-aldosterone system to clinical state in congestive heart failure. Circulation (1981) 1.90
Smooth, cardiac and skeletal muscle myosin force and motion generation assessed by cross-bridge mechanical interactions in vitro. J Muscle Res Cell Motil (1994) 1.85
Effects of different activity and inactivity paradigms on myosin heavy chain gene expression in striated muscle. J Appl Physiol (1985) (2001) 1.79
Skeletal muscle unweighting: spaceflight and ground-based models. J Appl Physiol (1985) (2003) 1.72
Why animals have different muscle fibre types. Nature (1988) 1.59
Cardiac disability. The impact of coronary heart disease on patients' daily activities. Arch Intern Med (1985) 1.50
Functional heterogeneity of mammalian single muscle fibres: do myosin isoforms tell the whole story? Pflugers Arch (2001) 1.50
Maximum specific force depends on myosin heavy chain content in rat diaphragm muscle fibers. J Appl Physiol (1985) (2000) 1.44
Randomized trial of progressive resistance training to counteract the myopathy of chronic heart failure. J Appl Physiol (1985) (2001) 1.24
Diaphragm single-fiber weakness and loss of myosin in congestive heart failure rats. Am J Physiol Heart Circ Physiol (2007) 1.20
Proteasome inhibition improves diaphragm function in congestive heart failure rats. Am J Physiol Lung Cell Mol Physiol (2008) 1.19
Reduced knee extensor function in heart failure is not explained by inactivity. Int J Cardiol (2009) 1.13
Oxidative capacity of skeletal muscle in heart failure patients versus sedentary or active control subjects. J Am Coll Cardiol (2001) 1.12
Altered expression of myosin heavy chain in human skeletal muscle in chronic heart failure. Med Sci Sports Exerc (1997) 1.05
Resistance training on physical performance in disabled older female cardiac patients. Med Sci Sports Exerc (2003) 1.04
Depression of force production and ATPase activity in different types of human skeletal muscle fibers from patients with chronic heart failure. J Appl Physiol (1985) (2005) 1.04
Serial circulating concentrations of C-reactive protein, interleukin (IL)-4, and IL-6 in patients with acute left heart decompensation. Clin Cardiol (1999) 1.04
Skeletal muscle myofibrillar protein metabolism in heart failure: relationship to immune activation and functional capacity. Am J Physiol Endocrinol Metab (2004) 1.03
Determinants of insulin-stimulated glucose disposal in middle-aged, premenopausal women. Am J Physiol Endocrinol Metab (2001) 1.02
Aging enhances indirect flight muscle fiber performance yet decreases flight ability in Drosophila. Biophys J (2008) 0.99
Factors contributing to the exercise limitation of heart failure. J Am Coll Cardiol (1993) 0.99
Skeletal muscle atrophy and peak oxygen consumption in heart failure. Am J Cardiol (1997) 0.99
Neurophysiological assessment of skeletal muscle fatigue in patients with congestive heart failure. Circulation (1992) 0.98
Myosin degradation fragments in skeletal muscle. J Mol Biol (1987) 0.96
Daily energy expenditure in free-living heart failure patients. Am J Physiol (1997) 0.93
REFINEMENTS IN METHOD OF EVALUATION AND PHYSICAL CONDITIONING BEFORE AND AFTER MYOCARDIAL INFARCTION. Am J Cardiol (1964) 0.93
Improvement of the measurements on skinned muscle fibres by fixation of the fibre ends with glutaraldehyde. J Muscle Res Cell Motil (1998) 0.86
Skeletal muscle myofibrillar mRNA expression in heart failure: relationship to local and circulating hormones. J Appl Physiol (1985) (2005) 0.86
Skeletal muscle myosin heavy chains in heart failure: correlation between magnitude of the isozyme shift, exercise capacity, and gas exchange measurements. Am Heart J (1998) 0.85
Subcellular localization of newly incorporated myosin in rabbit fast skeletal muscle undergoing stimulation-induced type transformation. J Muscle Res Cell Motil (1990) 0.85
Skeletal muscle contractile protein function is preserved in human heart failure. J Appl Physiol (1985) (2008) 0.84
Effect of heart failure on skeletal muscle myofibrillar protein content, isoform expression and calcium sensitivity. Int J Cardiol (2006) 0.83
Skeletal muscle characteristics, muscle strength and thigh muscle area in patients before and after cardiac transplantation. Eur J Heart Fail (2001) 0.80
Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy. Cell (2004) 11.33
FoxO3 coordinately activates protein degradation by the autophagic/lysosomal and proteasomal pathways in atrophying muscle cells. Cell Metab (2007) 8.05
PGC-1alpha protects skeletal muscle from atrophy by suppressing FoxO3 action and atrophy-specific gene transcription. Proc Natl Acad Sci U S A (2006) 5.28
Use of cardiac rehabilitation by Medicare beneficiaries after myocardial infarction or coronary bypass surgery. Circulation (2007) 4.74
Interventions to promote physical activity and dietary lifestyle changes for cardiovascular risk factor reduction in adults: a scientific statement from the American Heart Association. Circulation (2010) 3.63
Rapid disuse and denervation atrophy involve transcriptional changes similar to those of muscle wasting during systemic diseases. FASEB J (2006) 3.27
Exercise standards for testing and training: a scientific statement from the American Heart Association. Circulation (2013) 2.82
Weight loss reduces C-reactive protein levels in obese postmenopausal women. Circulation (2002) 2.46
Cardiac rehabilitation and survival in older coronary patients. J Am Coll Cardiol (2009) 2.45
Jade-1 inhibits Wnt signalling by ubiquitylating beta-catenin and mediates Wnt pathway inhibition by pVHL. Nat Cell Biol (2008) 2.34
Patterns of gene expression in atrophying skeletal muscles: response to food deprivation. FASEB J (2002) 2.29
The effect of weight loss and exercise training on flow-mediated dilatation in coronary heart disease: a randomized trial. Chest (2011) 2.15
High-calorie-expenditure exercise: a new approach to cardiac rehabilitation for overweight coronary patients. Circulation (2009) 2.08
Referral, enrollment, and delivery of cardiac rehabilitation/secondary prevention programs at clinical centers and beyond: a presidential advisory from the American Heart Association. Circulation (2011) 2.05
The muscle-specific ubiquitin ligase atrogin-1/MAFbx mediates statin-induced muscle toxicity. J Clin Invest (2007) 1.98
TNF-alpha increases ubiquitin-conjugating activity in skeletal muscle by up-regulating UbcH2/E220k. FASEB J (2003) 1.83
Tachycardia-induced diastolic dysfunction and resting tone in myocardium from patients with a normal ejection fraction. J Am Coll Cardiol (2011) 1.77
Chronic heart failure reduces Akt phosphorylation in human skeletal muscle: relationship to muscle size and function. J Appl Physiol (1985) (2010) 1.59
Human actin mutations associated with hypertrophic and dilated cardiomyopathies demonstrate distinct thin filament regulatory properties in vitro. J Mol Cell Cardiol (2009) 1.57
A re-examination of the metabolic equivalent concept in individuals with coronary heart disease. J Cardiopulm Rehabil Prev (2007) 1.54
Role of cardiac myosin binding protein C in sustaining left ventricular systolic stiffening. Circ Res (2004) 1.52
PhosphdiesteRasE-5 Inhibition to Improve CLinical Status and EXercise Capacity in Diastolic Heart Failure (RELAX) trial: rationale and design. Circ Heart Fail (2012) 1.46
Correlation of serum androgens with anthropometric and metabolic indices in healthy, nonobese postmenopausal women. J Clin Endocrinol Metab (2010) 1.46
Clinical evidence for a health benefit from cardiac rehabilitation: an update. Am Heart J (2006) 1.45
N-acetylcysteine-enhanced contrast provides cardiorenal protection. JACC Cardiovasc Interv (2009) 1.44
Gender alters the high-density lipoprotein cholesterol response to cardiac rehabilitation. J Cardiopulm Rehabil (2004) 1.44
Impaired muscle protein anabolic response to insulin and amino acids in heart failure patients: relationship with markers of immune activation. Clin Sci (Lond) (2010) 1.44
Cardiorenal rescue study in acute decompensated heart failure: rationale and design of CARRESS-HF, for the Heart Failure Clinical Research Network. J Card Fail (2012) 1.43
Deconvolution of mixture spectra from ion-trap data-independent-acquisition tandem mass spectrometry. Anal Chem (2010) 1.43
Unique single molecule binding of cardiac myosin binding protein-C to actin and phosphorylation-dependent inhibition of actomyosin motility requires 17 amino acids of the motif domain. J Mol Cell Cardiol (2011) 1.40
Corridor-based functional performance measures correlate better with physical activity during daily life than treadmill measures in persons with peripheral arterial disease. J Vasc Surg (2008) 1.36
The myosin converter domain modulates muscle performance. Nat Cell Biol (2002) 1.36
Ubiquitin-protein ligases in muscle wasting. Int J Biochem Cell Biol (2004) 1.35
Differential cross-bridge kinetics of FHC myosin mutations R403Q and R453C in heterozygous mouse myocardium. Am J Physiol Heart Circ Physiol (2004) 1.33
Two-state model of acto-myosin attachment-detachment predicts C-process of sinusoidal analysis. Biophys J (2007) 1.29
The challenge of achieving national cholesterol goals in patients with diabetes. Diabetes Care (2005) 1.27
An exceptionally fast actomyosin reaction powers insect flight muscle. Proc Natl Acad Sci U S A (2006) 1.24
The obesity paradox: perception vs knowledge. Mayo Clin Proc (2010) 1.20
Myosin light chain phosphorylation is critical for adaptation to cardiac stress. Circulation (2012) 1.19
Effect of cardiac myosin binding protein-C on mechanoenergetics in mouse myocardium. Circ Res (2004) 1.19
Atrogin-1 and MuRF1 regulate cardiac MyBP-C levels via different mechanisms. Cardiovasc Res (2009) 1.18
Chronic heart failure decreases cross-bridge kinetics in single skeletal muscle fibres from humans. J Physiol (2010) 1.17
Effects of cardiac myosin isoform variation on myofilament function and crossbridge kinetics in transgenic rabbits. Circ Heart Fail (2009) 1.16
Alternative N-terminal regions of Drosophila myosin heavy chain tune muscle kinetics for optimal power output. Biophys J (2004) 1.15
Peak aerobic capacity predicts prognosis in patients with coronary heart disease. Am Heart J (2008) 1.15
Menopause-related differences in inflammation markers and their relationship to body fat distribution and insulin-stimulated glucose disposal. Fertil Steril (2002) 1.15
The effect of hormone replacement therapy on body composition, body fat distribution, and insulin sensitivity in menopausal women: a randomized, double-blind, placebo-controlled trial. J Clin Endocrinol Metab (2005) 1.15
Calpain activity and muscle wasting in sepsis. Am J Physiol Endocrinol Metab (2008) 1.14
Reduced knee extensor function in heart failure is not explained by inactivity. Int J Cardiol (2009) 1.13
Effects of resistance training on physical function in older disabled women with coronary heart disease. J Appl Physiol (1985) (2002) 1.12
Roles for cardiac MyBP-C in maintaining myofilament lattice rigidity and prolonging myosin cross-bridge lifetime. Biophys J (2011) 1.11
Geographic distribution of cardiac rehabilitation programs in the United States. J Cardiopulm Rehabil (2005) 1.10
Immune activation is associated with reduced skeletal muscle mass and physical function in chronic heart failure. Int J Cardiol (2005) 1.08
Fibroblast cytoskeletal remodeling contributes to connective tissue tension. J Cell Physiol (2011) 1.07
Reduced cross-bridge dependent stiffness of skinned myocardium from mice lacking cardiac myosin binding protein-C. Mol Cell Biochem (2004) 1.07
Changing clinical profile of patients entering cardiac rehabilitation/secondary prevention programs: 1996 to 2006. J Cardiopulm Rehabil Prev (2008) 1.04
Myofilament mechanical performance is enhanced by R403Q myosin in mouse myocardium independent of sex. Am J Physiol Heart Circ Physiol (2008) 1.03
An alternative domain near the ATP binding pocket of Drosophila myosin affects muscle fiber kinetics. Biophys J (2006) 1.03
Resistance training alters skeletal muscle structure and function in human heart failure: effects at the tissue, cellular and molecular levels. J Physiol (2011) 1.03
Cardiac rehabilitation participation in underserved populations. Minorities, low socioeconomic, and rural residents. J Cardiopulm Rehabil Prev (2011) 1.02
Statin-induced muscle damage and atrogin-1 induction is the result of a geranylgeranylation defect. FASEB J (2009) 1.02
Alternative versions of the myosin relay domain differentially respond to load to influence Drosophila muscle kinetics. Biophys J (2008) 1.00
Aging enhances indirect flight muscle fiber performance yet decreases flight ability in Drosophila. Biophys J (2008) 0.99
Prevalence of metabolic syndrome in cardiac rehabilitation/secondary prevention programs. Am Heart J (2005) 0.99
Phosphorylation and the N-terminal extension of the regulatory light chain help orient and align the myosin heads in Drosophila flight muscle. J Struct Biol (2009) 0.99
Morphological and functional alterations in ventricular myocytes from male transgenic mice with hypertrophic cardiomyopathy. Circ Res (2003) 0.98
Reduction in obesity and coronary risk factors after high caloric exercise training in overweight coronary patients. Am Heart J (2003) 0.98
Flight muscle properties and aerodynamic performance of Drosophila expressing a flightin transgene. J Exp Biol (2005) 0.98
Age-related slowing of myosin actin cross-bridge kinetics is sex specific and predicts decrements in whole skeletal muscle performance in humans. J Appl Physiol (1985) (2013) 0.98
Paramyosin phosphorylation site disruption affects indirect flight muscle stiffness and power generation in Drosophila melanogaster. Proc Natl Acad Sci U S A (2005) 0.97
Effect of a daily supplement of soy protein on body composition and insulin secretion in postmenopausal women. Fertil Steril (2007) 0.97
The essential light chain N-terminal extension alters force and fiber kinetics in mouse cardiac muscle. J Biol Chem (2005) 0.96
Effects of endurance and resistance training on total daily energy expenditure in young women: a controlled randomized trial. J Clin Endocrinol Metab (2002) 0.96
Effect of resistance training on physical disability in chronic heart failure. Med Sci Sports Exerc (2011) 0.96
Cardiac myosin isoforms exhibit differential rates of MgADP release and MgATP binding detected by myocardial viscoelasticity. J Mol Cell Cardiol (2012) 0.95
Myofilament protein alterations promote physical disability in aging and disease. Exerc Sport Sci Rev (2013) 0.94
Factors Released from Embryonic Stem Cells Stimulate c-kit-FLK-1(+ve) Progenitor Cells and Enhance Neovascularization. Antioxid Redox Signal (2010) 0.94
Left ventricular end-diastolic volume is normal in patients with heart failure and a normal ejection fraction: a renewed consensus in diastolic heart failure. J Am Coll Cardiol (2007) 0.92